Impact of expanding HOPE Act experience criteria on program eligibility for transplantation from donors with human immunodeficiency virus to recipients with human immunodeficiency virus
Mary G. Bowring(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore), Dorry L. Segev(New York University), William A. Werbel(Johns Hopkins University), Jessica M. Ruck(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Mitchell G. Bryski(Johns Hopkins University), Allan B. Massie(Johns Hopkins University)
Cited by 9
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k